Solstice Oncology, Inc.
One private offering reported to the SEC on Form D since 2016, $121.3M sold in all. Biotech, MA.
- Form D offerings: 1
- Reported sold: $121.3M
- Newest: Mar 9, 2026
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Filed | Sold | Offering | Filed as | Last amended | Filing |
|---|---|---|---|---|---|
| Mar 9, 2026 | $121.3M | $298.4M | Solstice Oncology, Inc.Biotech · MA | Not amended | 0002116600-26-000002 |
SEC Profile
From the company's EDGAR record- Business address
- Boston, Ma
- Incorporated in
- DE
- All SEC filings
- CIK 2116600 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR